Relevant bibliographies by topics / Type 2 diabetes

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Type 2 diabetes'

Author: Grafiati
Published: 4 June 2021
Last updated: 7 September 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Type 2 diabetes.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Type 2 diabetes"

1

Khalid Iqbal, Rana. "Type 2 Diabetes and its Treatment." Diabetes & Obesity International Journal 4, no. 3 (2019): 1–3. http://dx.doi.org/10.23880/doij-16000208.

Full text
Abstract:
Type 2 diabetes is chronic disease that is spreading all over the world. In type 2 diabetes mainly there is less insulin production. It can be diet-induced and may also be associated with obesity. The body weight of a person increases due to more energy taken by the food, also the physical activity with less workout may lead to abdominal adiposity and finally the insulin resistance. Insulin resistance leads to the development of type 2 diabetes. The ratio of diabetic patients is increasing day by day. 90% of the total diabetic patients have type 2 diabetes. The risk of developing type 2diabetes is increasing according to an estimation of the American born in 2000 or later one of the three and some 50% members are expected to have type 2 diabetes.
APA, Harvard, Vancouver, ISO, and other styles
2

Sodikovna, Abdurazakova Dilbar, Yusupova Shahnoza Kadirjanovna, SaidjonovaFeruza Latifjonovna, and Jabbarov Ibrohimjon Adhamjon O’gli. "PREVENTION OF TYPE 2 DIABETES MELLITUS." American Journal Of Biomedical Science & Pharmaceutical Innovation 4, no. 3 (March 1, 2024): 44–51. http://dx.doi.org/10.37547/ajbspi/volume04issue03-06.

Full text
Abstract:
Prevention of type 2 diabetes mellitus and complications is an urgent problem in modern medicine. In patients with a body mass index (BMI) above 25 kg/m2, indicators of markers of carbohydrate metabolism (serum glucose -fasting and postprandial glycemia, glycosylated hemoglobin and urine glucose) and lipid metabolism -total cholesterol (TC), triglycerides (TG), lipidogram (low-density lipoprotein cholesterol -LDL cholesterol, atherogenic index -AI is significantly higher, and high-density lipoprotein cholesterol -HDL cholesterol is significantly lower than in patients with normal body mass index (BMI) and abdominal index (AI). Asignificant positive relationship between age, abdominal index, BMI, AI, glucose level in blood serum. Assessment of markers of carbohydrate and lipid metabolism should be included in the list of mandatory examinations of patients over the age of 30 years, and be strictly individual. There is a relationship between the progression of carbohydrate metabolism disorders and changes in lipid parameters metabolism in the examined women.The population should be widely informed about the development of type 2 diabetes mellitus and the progression of complications.
APA, Harvard, Vancouver, ISO, and other styles
3

Tian, Shen, Juan Wu, Jia-shuo Liu, Bao-shan Zou, and Ling-quan Kong. "Type 2 Diabetes." Annals of Internal Medicine 172, no. 10 (May 19, 2020): 704–5. http://dx.doi.org/10.7326/l20-0011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Vijan, Sandeep. "Type 2 Diabetes." Annals of Internal Medicine 172, no. 10 (May 19, 2020): 705. http://dx.doi.org/10.7326/l20-0012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Shimada, Akira. "Type 2 Diabetes." Nippon Shokuhin Kagaku Kogaku Kaishi 56, no. 12 (2009): 665. http://dx.doi.org/10.3136/nskkk.56.665.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Wilson, Jennifer F. "Type 2 Diabetes." Annals of Internal Medicine 146, no. 1 (January 2, 2007): ITC1–1. http://dx.doi.org/10.7326/0003-4819-146-1-200701020-01001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Vijan, Sandeep. "Type 2 Diabetes." Annals of Internal Medicine 152, no. 5 (March 2, 2010): ITC3–1. http://dx.doi.org/10.7326/0003-4819-152-5-201003020-01003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Quinn, Laurie. "TYPE 2 DIABETES." Nursing Clinics of North America 36, no. 2 (June 2001): 175–92. http://dx.doi.org/10.1016/s0029-6465(22)02543-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Vijan, Sandeep. "Type 2 Diabetes." Annals of Internal Medicine 162, no. 5 (March 3, 2015): ITC1. http://dx.doi.org/10.7326/aitc201503030.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Vijan, Sandeep. "Type 2 Diabetes." Annals of Internal Medicine 171, no. 9 (November 5, 2019): ITC65. http://dx.doi.org/10.7326/aitc201911050.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Type 2 diabetes"

1

Dow, Courtney. "Dietary Factors, Type 2 Diabetes and Diabetic Retinopathy." Thesis, Université Paris-Saclay (ComUE), 2018. http://www.theses.fr/2018SACLS380/document.

Full text
Abstract:
Contexte : Le diabète de type 2 (DT2) constitue une pathologie majeure, au lourd fardeau, associ ée à de nombreuses complications, comme la rétinopathie diabétique (RD). Des facteurs modifiables, comme l’alimentation, ont déjà été identifiés pour le DT2 et la RD mais certains aspects de leurs rôles restent à préciser. Objectifs : Les objectifs de cette thèse étaient d’examiner le rôle de l’alimentation, en particulier la consommation d’acides gras (AGs), et des autres facteurs modifiables liés au mode de vie sur le risque de DT2 et de synthétiser, interpréter et analyser la relation entre l’alimentation et la RD. Résultats : Les résultats suggèrent que le rôle des AGs sur le risque de DT2 et de la RD pourrait être différent selon leur type, et même varier au sein d’un groupe comme les AG polyinsaturés (AGPI). Les résultats suggèrent aussi qu’une forte adhésion aux recommandations alimentaires n’est pas associée avec le développement d’un DT2, mais en revanche une forte adhérence aux autres recommandations de santé (concernant le tour de taille, l’activité physique et le statut tabagique) est fortement associée avec un moindre risque de DT2. On a montré qu’avoir un mode de vie sain aurait pu empêcher la survenue de plus de la moitié des cas de DT2. Conclusions : Cette thèse a permis de préciser l’importance et la complexité du rôle de l’alimentation dans le développement du DT2 et de la RD. Elle montre aussi l’impact des comportements sains dans la pathologie de DT2 et confirme que le DT2 est en grande partie, une maladie évitable. Les efforts devraient se focaliser sur la modification des comportements de santé à la fois dans la population générale et atteinte de DT2 et notamment encourager une alimentation modérée et variée
Background : Type 2 diabetes (T2D) presents a significant health burden that is associated with many complications, such as diabetic retinopathy (DR), that further burden people with diabetes. Modifiable risk factors, such as the diet, have been identified for both T2D and DR; yet certain aspects of the role of the diet remain unclear. Objectives : The main objectives of this thesis were therefore to examine the role and impact of the diet, and in particular, the consumption of fatty acids (FAs), and other modifiable behaviours on the risk of T2D and to summarize, interpret and analyze the relationship between the diet and DR using data from both the E3N and AusDiab cohort studies. Results : The results suggest that the role of FAs on the risk of T2D and DR may differ between and within subgroups, and by individual polyunsaturated fatty acids (PUFAs). The findings also suggest that strongly adhering to national dietary guidelines is not associated with the development of T2D, but strongly adhering to other recommendations for healthy behaviours (for waist circumference, physical activity and smoking) is strongly inversely associated with T2D. Modifiable behaviour could have prevented more than half of the cases of T2D. Conclusions : This work underlines the importance and the complexity of the role of the diet in the development of T2D and DR. It also illustrates the impact of healthy behaviour in the etiology of T2D and confirms that T2D is largely preventable. Efforts should focus on the modification of multiple healthy behaviours in populations, and promote diets that are moderate and widely varied
APA, Harvard, Vancouver, ISO, and other styles
2

Sundsten, Tea. "Protein Profiling and Type 2 Diabetes." Doctoral thesis, Uppsala University, Department of Medical Cell Biology, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-8458.

Full text
Abstract:

Type 2 diabetes mellitus (T2DM) is a heterogeneous disease affecting millions of people worldwide. Both genetic and environmental factors contribute to the pathogenesis. The disease is characterized by alterations in many genes and their products. Historically, genomic alterations have mainly been studied at the transcriptional level in diabetes research. However, transcriptional changes do not always lead to altered translation, which makes it important to measure changes at the protein level. Proteomic techniques offer the possibility of measuring multiple protein alterations simultaneously.

In this thesis, the proteomic technique surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF MS) has been applied and evaluated in the context of T2DM research. Protocols for pancreatic islet and serum/plasma protein profiling and identification have been developed. In addition, the technique was used to analyze the influence of genetic background versus diabetic environment by determining serum protein profiles of individuals with normal glucose tolerance (NGT) and T2DM with or without family history of diabetes. In total thirteen serum proteins displayed different levels in serum from persons with NGT versus patients with T2DM. Among these proteins, apolipoprotein CIII, albumin and one yet unidentified protein could be classified as being changed because of different genetic backgrounds. On the other hand, ten proteins for instance transthyretin, differed as a result of the diabetic environment.

When plasma protein patterns of NGT and T2DM individuals characterized by differences in early insulin responses (EIR) were compared, nine proteins were found to be varying between the two groups. Of these proteins five were identified, namely two forms of transthyretin, hemoglobin α-chain, hemoglobin β-chain and apolipoprotein H. However no individual protein alone could explain the differences in EIR. In conclusion, SELDI-TOF MS has been successfully used in the context of T2DM research to identify proteins associated with family history of diabetes and β-bell function.

APA, Harvard, Vancouver, ISO, and other styles
3

Scott, Sarah R. "The management of type 2 diabetes." Thesis, University of Warwick, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.397095.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Lindsay, J. R. "Glycated peptides in type 2 diabetes." Thesis, Queen's University Belfast, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.269002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Steven, Sarah. "The reversibility of type 2 diabetes." Thesis, University of Newcastle upon Tyne, 2016. http://hdl.handle.net/10443/3177.

Full text
Abstract:
The incidence of both obesity and type 2 diabetes continues to rise, creating a major worldwide public health challenge. Understanding the mechanisms determining the normalisation of blood glucose levels and the limitations to complete reversal of diabetes by bariatric surgery or a very low calorie diet (VLCD) has important implications for the treatment of type 2 diabetes, but also for improving our understanding of the pathophysiology. A unifying hypothesis to explain the major pathophysiological changes in type 2 diabetes, hepatic insulin resistance and pancreatic beta cell insufficiency, involves excess triglyceride accumulation in liver and pancreas. This is supported by in vitro demonstration of impaired insulin signalling (and thereby insulin resistance) and defective insulin secretion, induced by the toxic metabolites of fat. Triglyceride content in liver and pancreas can now be measured non-invasively and precisely using the three point Dixon magnetic resonance technique. This thesis presents data on a direct comparison of bariatric surgery and VLCD, suggesting that the mechanisms involved in the reversibility of type 2 diabetes using these two interventions are similar. Pancreatic triglyceride content appears to decrease with substantial weight loss in obese individuals with type 2 diabetes but not those with normal glucose tolerance. The clinical characteristics which limit reversal of diabetes are investigated, particularly the effect of longer diabetes duration. Both a retrospective study of bariatric surgery and a prospective study using VLCD suggest that long duration diabetes is reversible, however, normal blood glucose levels are less likely to be achieved than in short duration disease. Diabetes duration may be a surrogate marker for beta cell reserve. Finally, the longer term durability of the beneficial effects of an 8 week very low calorie diet is demonstrated. Over a subsequent 6 month weight maintenance period the decrease in hepatic and pancreatic triglyceride content, and the improvements in hepatic insulin sensitivity and first phase insulin secretion are maintained. The latter appears to be a key mechanism for determining a glucose response to VLCD.
APA, Harvard, Vancouver, ISO, and other styles
6

Li, Luosheng. "Molecular genetics of type 2 diabetes /." Stockholm, 2002. http://diss.kib.ki.se/2002/91-7349-194-2/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Praet, Stephan Florent Eugenie. "Exercise therapy in Type 2 diabetes." Maarsen : Maastricht : Elsevier gezondheidszorg ; University Library, Universiteit Maastricht [host], 2007. http://arno.unimaas.nl/show.cgi?fid=9387.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Forbes, Shareen. "Catecholamine sensitivity preceding Type 2 diabetes." Thesis, Imperial College London, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.425685.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Gloyn, Anna Louise. "Molecular genetics of type 2 diabetes." Thesis, University of Oxford, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.343364.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Zhang, Yun. "Molecular genetics of type 2 diabetes." Thesis, University of Oxford, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.298425.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Type 2 diabetes"

1

Fried, Robert, and Richard M. Carlton. Type 2 Diabetes. Boca Raton : CRC Press, 2018.: CRC Press, 2018. http://dx.doi.org/10.1201/9780429507250.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Walker, Rosemary A. Type 2 Diabetes. London: Dorling Kindersley Limited, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Stocker, Claire, ed. Type 2 Diabetes. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-59745-448-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Stocker, Claire J., ed. Type 2 Diabetes. New York, NY: Springer New York, 2020. http://dx.doi.org/10.1007/978-1-4939-9882-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

J, Garber Alan, ed. Type 2 diabetes. Philadelphia: Saunders, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

English, Patrick. Type 2 Diabetes. London: Taylor & Francis Group Plc, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

English, Patrick. Type 2 diabetes. London: Dunitz, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Anthony, Barnett, ed. Type 2 diabetes. Oxford: Oxford University Press, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Mills, Jackie. Type 2 diabetes cookbook. Des Moines: Meredith Books, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

1930-, Ritz Eberhard, and Rychlík Ivan, eds. Nephropathy in type 2 diabetes. Oxford: Oxford University Press, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Type 2 diabetes"

1

Lansang, M. Cecilia, Richard David Leslie, Tahseen A. Chowdhury, and Keren Zhou. "Type 2 diabetes." In Diabetes, 34–48. 2nd ed. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/9781003240341-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Fried, Robert, and Richard M. Carlton. "Chronic Hyperglycemia—A Primer." In Type 2 Diabetes, 1–20. Boca Raton : CRC Press, 2018.: CRC Press, 2018. http://dx.doi.org/10.1201/9780429507250-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Fried, Robert, and Richard M. Carlton. "Selected Botanicals and Plant Products That Lower Blood Glucose (Continued)." In Type 2 Diabetes, 265–302. Boca Raton : CRC Press, 2018.: CRC Press, 2018. http://dx.doi.org/10.1201/9780429507250-10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Fried, Robert, and Richard M. Carlton. "Selected Functional Foods That Combat the Effects of Hyperglycemia and Chronic Inflammation." In Type 2 Diabetes, 303–46. Boca Raton : CRC Press, 2018.: CRC Press, 2018. http://dx.doi.org/10.1201/9780429507250-11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Fried, Robert, and Richard M. Carlton. "Functional Foods Continued." In Type 2 Diabetes, 347–68. Boca Raton : CRC Press, 2018.: CRC Press, 2018. http://dx.doi.org/10.1201/9780429507250-12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Fried, Robert, and Richard M. Carlton. "Selected Supplements That Support Glycemic Control and Reduce Chronic Inflammation." In Type 2 Diabetes, 369–404. Boca Raton : CRC Press, 2018.: CRC Press, 2018. http://dx.doi.org/10.1201/9780429507250-13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Fried, Robert, and Richard M. Carlton. "Additional Supplements That Support Glycemic Control and Reduce Chronic Inflammation." In Type 2 Diabetes, 405–46. Boca Raton : CRC Press, 2018.: CRC Press, 2018. http://dx.doi.org/10.1201/9780429507250-14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Fried, Robert, and Richard M. Carlton. "Hyperglycemia Impairs Blood Vessel Function." In Type 2 Diabetes, 21–54. Boca Raton : CRC Press, 2018.: CRC Press, 2018. http://dx.doi.org/10.1201/9780429507250-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Fried, Robert, and Richard M. Carlton. "Cardiovascular and Related Complications of Diabetes." In Type 2 Diabetes, 55–96. Boca Raton : CRC Press, 2018.: CRC Press, 2018. http://dx.doi.org/10.1201/9780429507250-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Fried, Robert, and Richard M. Carlton. "Hyperglycemia Impairs the Functions of Blood." In Type 2 Diabetes, 97–120. Boca Raton : CRC Press, 2018.: CRC Press, 2018. http://dx.doi.org/10.1201/9780429507250-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Type 2 diabetes"

1

Taher, Zahraaakhan. "Estimation of Thyroid Function Tests in Type 2 Diabetes Mellitus." In 5th International Conference on Biomedical and Health Sciences, 460–63. Cihan University-Erbil, 2024. http://dx.doi.org/10.24086/biohs2024/paper.1278.

Full text
Abstract:
Background and Objectives: Type 2 diabetes mellitus (T2DM) is an endocrine and metabolic disorder caused by insulin resistance, insulin hormone deficiency, and impaired insulin production form pancreatic beta cells. Thyroid hormones play a key role in glucose metabolism via several mechanisms. This study aimed to estimate the serum thyroid hormone levels in type 2 diabetic patients. Methods: The current case and control study was carried out in Erbil city. Blood specimens were collected from 100 subjects divided into two groups (50 case , 50 control). Each group consisted of (32 females and 18 males). The separate serum was used to determine the levels of thyroid stimulating hormone and thyroid hormones in diabetic patients and control subjects. Results: The results demonstrated that the serum thyroid hormones were significantly lower in patients with type 2 diabetes compared to healthy subjects. The mean ± SE was (3.58 ± 0.06) pmol/L and (14 ± 0.34) pmol/L, for triiodothyronine and thyroxine in type 2 diabetic patients, respectively. In addition, there was a significant difference in serum thyroxine levels among the grades of body mass index values in the case group. Conclusion: The study result concluded that type 2 diabetes mellitus could cause thyroid dysfunctions. It demonstrated that chronic hyperglycemia status in diabetes mellitus had a significant effect on serum thyroid hormone concentration.
APA, Harvard, Vancouver, ISO, and other styles
2

Berilli, Ana Luiza de Jesus, and Maria Luiza Ferreira Stringhini. "Type 2 diabetes mellitus and depression." In V Seven International Multidisciplinary Congress. Seven Congress, 2024. http://dx.doi.org/10.56238/sevenvmulti2024-072.

Full text
Abstract:
Type 2 diabetes mellitus (DM2) is a chronic non-communicable disease characterized by persistent hyperglycemia resulting from a deficiency in the synthesis and/or secretion of insulin by pancreatic b-cells, associated with other factors such as insulin resistance in peripheral tissues, hyperglucagonemia , increased hepatic gluconeogenesis, among others (American Diabetes Association, 2023; WHO, 2019). According to the International Diabetes Federation 2021, approximately 8.8% of the world's adult population has diabetes, of which 79% live in developing countries. Following this projection, it is estimated that by 2045 around 628.6 million individuals will have the disease.
APA, Harvard, Vancouver, ISO, and other styles
3

Anant, Karkhanis Apurva, Tushar Ghorpade, and Vimla Jethani. "Diabetic retinopathy detection through image mining for type 2 diabetes." In 2017 International Conference on Computer Communication and Informatics (ICCCI). IEEE, 2017. http://dx.doi.org/10.1109/iccci.2017.8117738.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Savira, Maya, Rusdiana, Sry Suryani Widjaja, and M. Syahputra. "Comparison of Ureum Plasma Level between Controlled Type 2 Diabetes Mellitus and Uncontrolled Type 2 Diabetes Mellitus." In International Conference of Science, Technology, Engineering, Environmental and Ramification Researches. SCITEPRESS - Science and Technology Publications, 2018. http://dx.doi.org/10.5220/0010077105250527.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

V, Menaka, Likitha V, Shravya M, and R. Pari. "Accurate Prediction of Type 1 and Type 2 Diabetes." In 2022 Third International Conference on Intelligent Computing Instrumentation and Control Technologies (ICICICT). IEEE, 2022. http://dx.doi.org/10.1109/icicict54557.2022.9917938.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Maalouf, Naim M., James C. Williams, Andrew P. Evan, James E. Lingeman, and James A. McAteer. "Type 2 Diabetes and Uric Acid Nephrolithiasis." In RENAL STONE DISEASE 2: 2nd International Urolithiasis Research Symposium. AIP, 2008. http://dx.doi.org/10.1063/1.2998021.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Zeitler, Phil. "9 Advances in therapeutics for type 2 diabetes." In The 7th ASPED-ISPAD Diabetes Academy. BMJ Publishing Group Ltd, 2024. http://dx.doi.org/10.1136/bmjpo-2024-asped.9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Krogvold, Lars. "2 Delaying the development of type 1 diabetes." In The 7th ASPED-ISPAD Diabetes Academy. BMJ Publishing Group Ltd, 2024. http://dx.doi.org/10.1136/bmjpo-2024-asped.2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Christen, Alejandra. "Arterial evaluation in type 2 diabetes mellitus." In 2010 32nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC 2010). IEEE, 2010. http://dx.doi.org/10.1109/iembs.2010.5627474.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Rufino, Rogério L., Rogério M. Bartholo, Thiago P. Bartholo, Claudia Costa, Agnaldo Lopes, Marília Gomes, Cátia Souza, and Andrei Melo. "Induced Sputum And Type 2 Diabetes Mellitus." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a1775.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Type 2 diabetes"

1

Vis, Dalton. SGLT2 Inhibitors and Type 2 Diabetes. Ames (Iowa): Iowa State University, May 2022. http://dx.doi.org/10.31274/cc-20240624-1281.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Faller, Rachel, Tracy Gregory, Michelle Jones, Peyton Barnett, and Laura Reed. Effect of Certified Diabetes Clinical Education Specialists on Adults with Type 2 Diabetes. University of Tennessee Health Science Center, April 2024. http://dx.doi.org/10.21007/con.dnp.2024.0077.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Zaharieva, Emanuela, Elena Vikentieva, Rosica Andreeva, Dora Popova, and Zdravko Kamenov. CD36 Surface Expression on Monocytes in Type 2 Diabetes. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, April 2018. http://dx.doi.org/10.7546/crabs.2019.04.14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Katz, Richard, Michelle Magee, Gail Nunlee-Bland, Pamela Johnson, Linda Witkin, Carine Nassar, Clayton Bourges, et al. Comparing Three Methods to Help Patients Manage Type 2 Diabetes. Patient-Centered Outcomes Research Institute® (PCORI), July 2019. http://dx.doi.org/10.25302/4.2019.ih.13046797.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Heymsfield, Steven, Carol Boushey, Heather Leidy, Richard Mattes, Ronald Kleinman, Emily Callahan, Gisela Butera, Nancy Terry, and Julie Obbagy. Frequency of Eating and Type 2 Diabetes: A Systematic Review. U.S. Department of Agriculture, Food and Nutrition Service, Center for Nutrition Policy and Promotion, Nutrition Evidence Systematic Review, July 2020. http://dx.doi.org/10.52570/nesr.dgac2020.sr0603.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Wang, Wei, and Yi Wu. Prediction models for diabetic retinopathy development in type 2 diabetes mellitus patients: a systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, March 2022. http://dx.doi.org/10.37766/inplasy2022.3.0089.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Boushey, Carol, Jamy Ard, Lydia Bazzano, Steven Heymsfield, Elizabeth Mayer-Davis, Joan Sabaté, Linda Snetselaar, et al. Dietary Patterns and Risk of Type 2 Diabetes: A Systematic Review. U.S. Department of Agriculture, Food and Nutrition Service, Center for Nutrition Policy and Promotion, Nutrition Evidence Systematic Review, July 2020. http://dx.doi.org/10.52570/nesr.dgac2020.sr0103.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Norris, John, Robin Gordon, Margaret Harvey, and Laura Reed. Utilization of Depression Screening in Patients with Type 2 Diabetes Mellitus. University of Tennessee Health Science Center, May 2024. http://dx.doi.org/10.21007/con.dnp.2024.0095.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Mei, Manxue, Min Jiang, Zunjiang Li, Wei Zhu, and Jianping Song. Meditation Programs for Adults with Type 2 Diabetes Mellitus: Protocol for a Systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, October 2021. http://dx.doi.org/10.37766/inplasy2021.10.0008.

Full text
Abstract:
Review question / Objective: Would meditation programs affect fasting blood glucose levels and HbA(1c) of patients with type 2 diabetes mellitus? Would meditation programs intervention be of benefit for remission of depression and anxiety level? Would meditation programs improve quality of life of individuals with type 2 diabetes？ Do meditation programs affect body mass index (BMI), serum lipid levels and level of blood pressure? Which type of meditation programs is better for type 2 diabetes patients? Are there any differences of efficacy among different meditation programs? To provide valid evidence for the effect of meditation programs for type 2 diabetes by synthesizing and comparing outcomes from clinical trials. Main outcome(s): The outcomes include fasting blood glucose levels and HbA(1c).
APA, Harvard, Vancouver, ISO, and other styles
10

Lai, Pei Kuan, Cheong Lieng Teng, and Feisul Idzwan Mustapha. Health Knowledge among Type 2 Diabetes Patients in Malaysia: A Systematic Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2021. http://dx.doi.org/10.37766/inplasy2021.9.0044.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Type 2 diabetes' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography